Login / Signup

Orthogonal CRISPR-associated transposases for parallel and multiplexed chromosomal integration.

Siqi YangYiwen ZhangJiaqi XuJiao ZhangJieze ZhangJunjie YangYu JiangSheng Yang
Published in: Nucleic acids research (2021)
Cell engineering is commonly limited to the serial manipulation of a single gene or locus. The recently discovered CRISPR-associated transposases (CASTs) could manipulate multiple sets of genes to achieve predetermined cell diversity, with orthogonal CASTs being able to manipulate them in parallel. Here, a novel CAST from Pseudoalteromonas translucida KMM520 (PtrCAST) was characterized without a protospacer adjacent motif (PAM) preference which can achieve a high insertion efficiency for larger cargo and multiplexed transposition and tolerate mismatches out of 4-nucleotide seed sequence. More importantly, PtrCAST operates orthogonally with CAST from Vibrio cholerae Tn6677 (VchCAST), though both belonging to type I-F3. The two CASTs were exclusively active on their respective mini-Tn substrate with their respective crRNAs that target the corresponding 5 and 2 loci in one Escherichia coli cell. The multiplexed orthogonal MUCICAT (MUlticopy Chromosomal Integration using CRISPR-Associated Transposases) is a powerful tool for cell programming and appears promising with applications in synthetic biology.
Keyphrases
  • single cell
  • genome wide
  • escherichia coli
  • cell therapy
  • crispr cas
  • copy number
  • dna methylation
  • gene expression
  • stem cells
  • bone marrow
  • pseudomonas aeruginosa
  • transcription factor
  • staphylococcus aureus